Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force.

Faragalla, Hala; Plotkin, Anna; Barnes, Penny; Lu, Fang-I; Kos, Zuzana; Mulligan, Anna Marie; Bane, Anita; Nofech Mozes, Sharon

Faragalla, Hala; Plotkin, Anna; Barnes, Penny; Lu, Fang-I; Kos, Zuzana; Mulligan, Anna Marie; Bane, Anita; Nofech Mozes, Sharon.

Afiliação

Faragalla H; Department of Laboratory Medicine, St. Michael's Hospital, Toronto, ON M5B 1W8, Canada.
Plotkin A; Department of Laboratory Medicine and Molecular Diagnostics Sunnybrook Health Sciences Center, Toronto, ON M4N 3M5, Canada.
Barnes P; Department of Pathology and Laboratory Medicine, Nova Scotia Health Authority, Halifax, NS B3H 2E2, Canada.
Lu FI; Department of Laboratory Medicine and Molecular Diagnostics Sunnybrook Health Sciences Center, Toronto, ON M4N 3M5, Canada.
Kos Z; Department of Pathology, BC Cancer, Vancouver, BC V5Z 4E6, Canada.
Mulligan AM; Department of Laboratory Medicine, University Health Network, Toronto, ON M5T 2S8, Canada.
Bane A; Department of Laboratory Medicine, University Health Network, Toronto, ON M5T 2S8, Canada.
Nofech Mozes S; Department of Laboratory Medicine and Molecular Diagnostics Sunnybrook Health Sciences Center, Toronto, ON M4N 3M5, Canada.

Curr Oncol ; 30(3): 3079-3090, 2023 03 06.

Article em En | MEDLINE | ID: mdl-36975446

Assuntos

Neoplasias da Mama; Humanos; Feminino; Neoplasias da Mama/patologia; Antígeno Ki-67/análise; Patologistas; Reprodutibilidade dos Testes; Canadá

Palavras-chave

Ki67 breast cancer; MonarchE trial; advanced early-stage breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País como assunto: America do norte Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google